mouse left ventricular na v channel protein complexes Search Results


95
Alomone Labs mouse left ventricular na v channel protein complexes
Phosphorylation sites, phosphopeptides, and site-discriminating ions identified in <t> immunoprecipitated </t> <t> Na V </t> 1.5 proteins from sham and TAC mouse left ventricles using MS
Mouse Left Ventricular Na V Channel Protein Complexes, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/pmc07797897-155-39-77?v=Alomone+Labs
Average 95 stars, based on 1 article reviews
mouse left ventricular na v channel protein complexes - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

96
Alomone Labs rabbit polyclonal anti na v 1 5
Expression of Na V 1.8 in the human atrium. Data are presented as scatter plot with mean ± SEM. P values were calculated using unpaired Student's t test. a Original Western blot for Na V 1.8 expression in atrial myocardium from patients with sinus rhythm compared to ventricular myocardium from non-failing donors (NF). b Normalized densitometry data comparing the protein expression of Na V 1.8 in human atria ( n = 6) and human ventricle ( n = 5). GAPDH was used as an internal loading control in all blots. c Normalized mRNA expression of Na V 1.8/GAPDH in human atrial myocardium ( n = 7 patients) compared to ventricular myocardium from healthy subjects ( n = 10 patients). d Original Western Blot for Na V 1.8 and Na V 1.5 protein in human atria from patients with sinus rhythm (SR) or atrial fibrillation (AF). e Normalized densitometry data from Western Blots using atrial myocardium from patients with SR or AF showing the protein expression of Na V 1.5 (SR: n = 14 patients, AF: n = 13) and ( f ) Na V 1.8 (SR: n = 14 patients, AF: n = 14). GAPDH was used as an internal loading control in all blots. g Normalized mRNA expression of Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) and Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) in human atrial myocardium from SR compared to AF
Rabbit Polyclonal Anti Na V 1 5, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/pmc07033079-51-9-15?v=Alomone+Labs
Average 96 stars, based on 1 article reviews
rabbit polyclonal anti na v 1 5 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

95
Alomone Labs na v 1 1
Expression of Na V 1.8 in the human atrium. Data are presented as scatter plot with mean ± SEM. P values were calculated using unpaired Student's t test. a Original Western blot for Na V 1.8 expression in atrial myocardium from patients with sinus rhythm compared to ventricular myocardium from non-failing donors (NF). b Normalized densitometry data comparing the protein expression of Na V 1.8 in human atria ( n = 6) and human ventricle ( n = 5). GAPDH was used as an internal loading control in all blots. c Normalized mRNA expression of Na V 1.8/GAPDH in human atrial myocardium ( n = 7 patients) compared to ventricular myocardium from healthy subjects ( n = 10 patients). d Original Western Blot for Na V 1.8 and Na V 1.5 protein in human atria from patients with sinus rhythm (SR) or atrial fibrillation (AF). e Normalized densitometry data from Western Blots using atrial myocardium from patients with SR or AF showing the protein expression of Na V 1.5 (SR: n = 14 patients, AF: n = 13) and ( f ) Na V 1.8 (SR: n = 14 patients, AF: n = 14). GAPDH was used as an internal loading control in all blots. g Normalized mRNA expression of Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) and Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) in human atrial myocardium from SR compared to AF
Na V 1 1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/pmc05927368-138-2-5?v=Alomone+Labs
Average 95 stars, based on 1 article reviews
na v 1 1 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

95
Alomone Labs mouse nav subtype
Expression of Na V 1.8 in the human atrium. Data are presented as scatter plot with mean ± SEM. P values were calculated using unpaired Student's t test. a Original Western blot for Na V 1.8 expression in atrial myocardium from patients with sinus rhythm compared to ventricular myocardium from non-failing donors (NF). b Normalized densitometry data comparing the protein expression of Na V 1.8 in human atria ( n = 6) and human ventricle ( n = 5). GAPDH was used as an internal loading control in all blots. c Normalized mRNA expression of Na V 1.8/GAPDH in human atrial myocardium ( n = 7 patients) compared to ventricular myocardium from healthy subjects ( n = 10 patients). d Original Western Blot for Na V 1.8 and Na V 1.5 protein in human atria from patients with sinus rhythm (SR) or atrial fibrillation (AF). e Normalized densitometry data from Western Blots using atrial myocardium from patients with SR or AF showing the protein expression of Na V 1.5 (SR: n = 14 patients, AF: n = 13) and ( f ) Na V 1.8 (SR: n = 14 patients, AF: n = 14). GAPDH was used as an internal loading control in all blots. g Normalized mRNA expression of Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) and Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) in human atrial myocardium from SR compared to AF
Mouse Nav Subtype, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/10__4103_slash_nrr__nrr___d___23___00756-85-19-47?v=Alomone+Labs
Average 95 stars, based on 1 article reviews
mouse nav subtype - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

93
Alomone Labs polyclonal rabbit antibody against na v 1 2
Expression of Na V 1.8 in the human atrium. Data are presented as scatter plot with mean ± SEM. P values were calculated using unpaired Student's t test. a Original Western blot for Na V 1.8 expression in atrial myocardium from patients with sinus rhythm compared to ventricular myocardium from non-failing donors (NF). b Normalized densitometry data comparing the protein expression of Na V 1.8 in human atria ( n = 6) and human ventricle ( n = 5). GAPDH was used as an internal loading control in all blots. c Normalized mRNA expression of Na V 1.8/GAPDH in human atrial myocardium ( n = 7 patients) compared to ventricular myocardium from healthy subjects ( n = 10 patients). d Original Western Blot for Na V 1.8 and Na V 1.5 protein in human atria from patients with sinus rhythm (SR) or atrial fibrillation (AF). e Normalized densitometry data from Western Blots using atrial myocardium from patients with SR or AF showing the protein expression of Na V 1.5 (SR: n = 14 patients, AF: n = 13) and ( f ) Na V 1.8 (SR: n = 14 patients, AF: n = 14). GAPDH was used as an internal loading control in all blots. g Normalized mRNA expression of Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) and Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) in human atrial myocardium from SR compared to AF
Polyclonal Rabbit Antibody Against Na V 1 2, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/pmc02785851-107-15-22?v=Alomone+Labs
Average 93 stars, based on 1 article reviews
polyclonal rabbit antibody against na v 1 2 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

95
Alomone Labs nav 1 8
Dose-dependent recovery of voltage-gated sodium (NaV) channel expression in dorsal root ganglia (DRG) of cilostazol-treated diabetic (DM) rats. Expressions of NaV-1.1, -1.2, -1.3, -1.6, -1.7, and -1.8 in DRG of naïve control, DM, and oral cilostazol (10, 30, and 100 mg/kg) treated DM rats were examined with (A) Western blots and (B) immunofluorescence assays. The western and immunofluorescence data revealed significant upregulation of NaV-1.1–1.7 expressions, and significant downregulation of <t>NaV-1.8</t> in the DRGs of DM rats. Daily oral cilostazol treatments of 100 mg/kg, but not the lower dosages, for 6 weeks significantly reversed the DM-induced NaV dysregulation in the DRGs. Results are expressed as mean SEM for a minimum of five rats for each group. Statistical significances between the DM control and cilostazol DM treatment groups were calculated by one-way ANOVA analysis followed by the least significant difference test for multiple post hoc analyses. ** p < 0.01, * p < 0.05, *** p < 0.001.
Nav 1 8, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/pmc08804339-54-50-35?v=Alomone+Labs
Average 95 stars, based on 1 article reviews
nav 1 8 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

94
Alomone Labs rabbit anti na v 1 5
Dose-dependent recovery of voltage-gated sodium (NaV) channel expression in dorsal root ganglia (DRG) of cilostazol-treated diabetic (DM) rats. Expressions of NaV-1.1, -1.2, -1.3, -1.6, -1.7, and -1.8 in DRG of naïve control, DM, and oral cilostazol (10, 30, and 100 mg/kg) treated DM rats were examined with (A) Western blots and (B) immunofluorescence assays. The western and immunofluorescence data revealed significant upregulation of NaV-1.1–1.7 expressions, and significant downregulation of <t>NaV-1.8</t> in the DRGs of DM rats. Daily oral cilostazol treatments of 100 mg/kg, but not the lower dosages, for 6 weeks significantly reversed the DM-induced NaV dysregulation in the DRGs. Results are expressed as mean SEM for a minimum of five rats for each group. Statistical significances between the DM control and cilostazol DM treatment groups were calculated by one-way ANOVA analysis followed by the least significant difference test for multiple post hoc analyses. ** p < 0.01, * p < 0.05, *** p < 0.001.
Rabbit Anti Na V 1 5, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/pmc12520690-202-32-36?v=Alomone+Labs
Average 94 stars, based on 1 article reviews
rabbit anti na v 1 5 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

91
Proteintech anti na v 1 5
Dose-dependent recovery of voltage-gated sodium (NaV) channel expression in dorsal root ganglia (DRG) of cilostazol-treated diabetic (DM) rats. Expressions of NaV-1.1, -1.2, -1.3, -1.6, -1.7, and -1.8 in DRG of naïve control, DM, and oral cilostazol (10, 30, and 100 mg/kg) treated DM rats were examined with (A) Western blots and (B) immunofluorescence assays. The western and immunofluorescence data revealed significant upregulation of NaV-1.1–1.7 expressions, and significant downregulation of <t>NaV-1.8</t> in the DRGs of DM rats. Daily oral cilostazol treatments of 100 mg/kg, but not the lower dosages, for 6 weeks significantly reversed the DM-induced NaV dysregulation in the DRGs. Results are expressed as mean SEM for a minimum of five rats for each group. Statistical significances between the DM control and cilostazol DM treatment groups were calculated by one-way ANOVA analysis followed by the least significant difference test for multiple post hoc analyses. ** p < 0.01, * p < 0.05, *** p < 0.001.
Anti Na V 1 5, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/pmc11532958-288-20-23?v=Proteintech
Average 91 stars, based on 1 article reviews
anti na v 1 5 - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

90
NeuroMab anti-na v 1.1 clone k74/71
Dose-dependent recovery of voltage-gated sodium (NaV) channel expression in dorsal root ganglia (DRG) of cilostazol-treated diabetic (DM) rats. Expressions of NaV-1.1, -1.2, -1.3, -1.6, -1.7, and -1.8 in DRG of naïve control, DM, and oral cilostazol (10, 30, and 100 mg/kg) treated DM rats were examined with (A) Western blots and (B) immunofluorescence assays. The western and immunofluorescence data revealed significant upregulation of NaV-1.1–1.7 expressions, and significant downregulation of <t>NaV-1.8</t> in the DRGs of DM rats. Daily oral cilostazol treatments of 100 mg/kg, but not the lower dosages, for 6 weeks significantly reversed the DM-induced NaV dysregulation in the DRGs. Results are expressed as mean SEM for a minimum of five rats for each group. Statistical significances between the DM control and cilostazol DM treatment groups were calculated by one-way ANOVA analysis followed by the least significant difference test for multiple post hoc analyses. ** p < 0.01, * p < 0.05, *** p < 0.001.
Anti Na V 1.1 Clone K74/71, supplied by NeuroMab, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/pmc05431801-194-8-18?v=NeuroMab
Average 90 stars, based on 1 article reviews
anti-na v 1.1 clone k74/71 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

94
Alomone Labs anti pan mglu 5
Dose-dependent recovery of voltage-gated sodium (NaV) channel expression in dorsal root ganglia (DRG) of cilostazol-treated diabetic (DM) rats. Expressions of NaV-1.1, -1.2, -1.3, -1.6, -1.7, and -1.8 in DRG of naïve control, DM, and oral cilostazol (10, 30, and 100 mg/kg) treated DM rats were examined with (A) Western blots and (B) immunofluorescence assays. The western and immunofluorescence data revealed significant upregulation of NaV-1.1–1.7 expressions, and significant downregulation of <t>NaV-1.8</t> in the DRGs of DM rats. Daily oral cilostazol treatments of 100 mg/kg, but not the lower dosages, for 6 weeks significantly reversed the DM-induced NaV dysregulation in the DRGs. Results are expressed as mean SEM for a minimum of five rats for each group. Statistical significances between the DM control and cilostazol DM treatment groups were calculated by one-way ANOVA analysis followed by the least significant difference test for multiple post hoc analyses. ** p < 0.01, * p < 0.05, *** p < 0.001.
Anti Pan Mglu 5, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/pmc04481196-31-38-40?v=Alomone+Labs
Average 94 stars, based on 1 article reviews
anti pan mglu 5 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
Alomone Labs na v
Dose-dependent recovery of voltage-gated sodium (NaV) channel expression in dorsal root ganglia (DRG) of cilostazol-treated diabetic (DM) rats. Expressions of NaV-1.1, -1.2, -1.3, -1.6, -1.7, and -1.8 in DRG of naïve control, DM, and oral cilostazol (10, 30, and 100 mg/kg) treated DM rats were examined with (A) Western blots and (B) immunofluorescence assays. The western and immunofluorescence data revealed significant upregulation of NaV-1.1–1.7 expressions, and significant downregulation of <t>NaV-1.8</t> in the DRGs of DM rats. Daily oral cilostazol treatments of 100 mg/kg, but not the lower dosages, for 6 weeks significantly reversed the DM-induced NaV dysregulation in the DRGs. Results are expressed as mean SEM for a minimum of five rats for each group. Statistical significances between the DM control and cilostazol DM treatment groups were calculated by one-way ANOVA analysis followed by the least significant difference test for multiple post hoc analyses. ** p < 0.01, * p < 0.05, *** p < 0.001.
Na V, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/pmc06289662-79-35-42?v=Alomone+Labs
Average 94 stars, based on 1 article reviews
na v - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

95
Alomone Labs t5648 chemical compound
Dose-dependent recovery of voltage-gated sodium (NaV) channel expression in dorsal root ganglia (DRG) of cilostazol-treated diabetic (DM) rats. Expressions of NaV-1.1, -1.2, -1.3, -1.6, -1.7, and -1.8 in DRG of naïve control, DM, and oral cilostazol (10, 30, and 100 mg/kg) treated DM rats were examined with (A) Western blots and (B) immunofluorescence assays. The western and immunofluorescence data revealed significant upregulation of NaV-1.1–1.7 expressions, and significant downregulation of <t>NaV-1.8</t> in the DRGs of DM rats. Daily oral cilostazol treatments of 100 mg/kg, but not the lower dosages, for 6 weeks significantly reversed the DM-induced NaV dysregulation in the DRGs. Results are expressed as mean SEM for a minimum of five rats for each group. Statistical significances between the DM control and cilostazol DM treatment groups were calculated by one-way ANOVA analysis followed by the least significant difference test for multiple post hoc analyses. ** p < 0.01, * p < 0.05, *** p < 0.001.
T5648 Chemical Compound, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+left+ventricular+na+v+channel+protein+complexes/10__7554_slash_elife__71575-371-182-188?v=Alomone+Labs
Average 95 stars, based on 1 article reviews
t5648 chemical compound - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

Image Search Results


Phosphorylation sites, phosphopeptides, and site-discriminating ions identified in  immunoprecipitated   Na V  1.5 proteins from sham and TAC mouse left ventricles using MS

Journal: The Journal of General Physiology

Article Title: Proteomic and functional mapping of cardiac Na V 1.5 channel phosphorylation sites

doi: 10.1085/jgp.202012646

Figure Lengend Snippet: Phosphorylation sites, phosphopeptides, and site-discriminating ions identified in immunoprecipitated Na V 1.5 proteins from sham and TAC mouse left ventricles using MS

Article Snippet: Magnetic beads were then collected and washed rapidly four times with ice-cold lysis buffer, and isolated protein complexes were eluted from the beads in 1× SDS sample buffer (Bio-Rad Laboratories) at 60°C for 10 min. 99% of the immunoprecipitated mouse left ventricular Na V channel protein complexes were analyzed by MS, and the remaining 1% were used to verify IP yields by Western blotting using a rabbit polyclonal anti-Na V 1.5 antibody (RbαNa V 1.5, 1:1,000, ASC-005; Alomone Laboratories).

Techniques: Immunoprecipitation, Sequencing

Localization and quantification of 42 MS-identified Na V 1.5 phosphorylation sites in mαNa V PAN-IPs from sham and TAC mouse left ventricles (LVs). (A) Schematic representation of phosphorylation sites on the Na V 1.5 protein (UniProt reference sequence K3W4N7 ). Two phosphorylation site locations are possible at amino acids S1056-T1058. (B) The areas of extracted MS1 ion chromatograms, corresponding to MS2 spectra assigning phosphorylated (in red) and nonphosphorylated (in white) Na V 1.5 peptides at indicated phosphorylation site(s), in mαNa V PAN-IPs from sham and TAC LVs are indicated. No red color is visible for the phosphorylated peptide at position T1809, because this phosphopeptide area is very small (area = 80,291 arbitrary unit) relative to the areas of the nonphosphorylated peptides (areas = 80,060,220 arbitrary unit). (C) The areas of extracted MS1 ion chromatograms, corresponding to MS2 spectra assigning phosphorylated peptides at indicated phosphorylation site(s), in mαNa V PAN-IPs from sham and TAC LVs are indicated. The brackets indicate the subgroups of phosphorylation sites analyzed in B. Independent quantification of S459 and S460 phosphorylated peptides was not possible, because localization of the phosphorylation site in most of the phosphorylated peptides could not be discriminated. Similar to B, no red bar is visible for the phosphorylated peptide at position T1809, because this phosphopeptide area is very small (area = 80,291 arbitrary unit), relative to the areas of the other phosphorylated peptides. (D) Distributions and mean ± SEM relative abundances of individual Na V 1.5 phosphopeptides allowing assignments of indicated phosphorylation site(s), as well as of corresponding nonphosphorylated (NP) peptides, in TAC LV ( n = 5, in black) versus sham LV ( n = 4, in white) mαNa V PAN-IPs were obtained using TMT reporter ion intensities. The relative abundances of Na V 1.5 phosphopeptides exhibiting phosphorylation(s) on serine 671 (S671; n = 12 peptides) alone or in combination with serine 664 (S664 + S671; n = 9 peptides) or serine 667 (S667 + S671; n = 7 peptides) are increased (**, P < 0.01; ***, P < 0.001; Mann-Whitney test) in TAC LV versus sham LV mαNa V PAN-IPs. (E) Experimental workflow used in the study. Once immunoprecipitated using the mαNa V PAN antibodies, the Na V channel complexes from sham and TAC mouse LVs were labeled individually with different TMT 10 tags and combined in the same TMT set for multiplexed LC-MS/MS analysis. Na V 1.5 phosphorylation sites were identified, quantified, and analyzed by clusters in whole-cell voltage-clamp recordings in HEK-293 cells.

Journal: The Journal of General Physiology

Article Title: Proteomic and functional mapping of cardiac Na V 1.5 channel phosphorylation sites

doi: 10.1085/jgp.202012646

Figure Lengend Snippet: Localization and quantification of 42 MS-identified Na V 1.5 phosphorylation sites in mαNa V PAN-IPs from sham and TAC mouse left ventricles (LVs). (A) Schematic representation of phosphorylation sites on the Na V 1.5 protein (UniProt reference sequence K3W4N7 ). Two phosphorylation site locations are possible at amino acids S1056-T1058. (B) The areas of extracted MS1 ion chromatograms, corresponding to MS2 spectra assigning phosphorylated (in red) and nonphosphorylated (in white) Na V 1.5 peptides at indicated phosphorylation site(s), in mαNa V PAN-IPs from sham and TAC LVs are indicated. No red color is visible for the phosphorylated peptide at position T1809, because this phosphopeptide area is very small (area = 80,291 arbitrary unit) relative to the areas of the nonphosphorylated peptides (areas = 80,060,220 arbitrary unit). (C) The areas of extracted MS1 ion chromatograms, corresponding to MS2 spectra assigning phosphorylated peptides at indicated phosphorylation site(s), in mαNa V PAN-IPs from sham and TAC LVs are indicated. The brackets indicate the subgroups of phosphorylation sites analyzed in B. Independent quantification of S459 and S460 phosphorylated peptides was not possible, because localization of the phosphorylation site in most of the phosphorylated peptides could not be discriminated. Similar to B, no red bar is visible for the phosphorylated peptide at position T1809, because this phosphopeptide area is very small (area = 80,291 arbitrary unit), relative to the areas of the other phosphorylated peptides. (D) Distributions and mean ± SEM relative abundances of individual Na V 1.5 phosphopeptides allowing assignments of indicated phosphorylation site(s), as well as of corresponding nonphosphorylated (NP) peptides, in TAC LV ( n = 5, in black) versus sham LV ( n = 4, in white) mαNa V PAN-IPs were obtained using TMT reporter ion intensities. The relative abundances of Na V 1.5 phosphopeptides exhibiting phosphorylation(s) on serine 671 (S671; n = 12 peptides) alone or in combination with serine 664 (S664 + S671; n = 9 peptides) or serine 667 (S667 + S671; n = 7 peptides) are increased (**, P < 0.01; ***, P < 0.001; Mann-Whitney test) in TAC LV versus sham LV mαNa V PAN-IPs. (E) Experimental workflow used in the study. Once immunoprecipitated using the mαNa V PAN antibodies, the Na V channel complexes from sham and TAC mouse LVs were labeled individually with different TMT 10 tags and combined in the same TMT set for multiplexed LC-MS/MS analysis. Na V 1.5 phosphorylation sites were identified, quantified, and analyzed by clusters in whole-cell voltage-clamp recordings in HEK-293 cells.

Article Snippet: Magnetic beads were then collected and washed rapidly four times with ice-cold lysis buffer, and isolated protein complexes were eluted from the beads in 1× SDS sample buffer (Bio-Rad Laboratories) at 60°C for 10 min. 99% of the immunoprecipitated mouse left ventricular Na V channel protein complexes were analyzed by MS, and the remaining 1% were used to verify IP yields by Western blotting using a rabbit polyclonal anti-Na V 1.5 antibody (RbαNa V 1.5, 1:1,000, ASC-005; Alomone Laboratories).

Techniques: Sequencing, MANN-WHITNEY, Immunoprecipitation, Labeling, Liquid Chromatography with Mass Spectroscopy

Proteins identified in  immunoprecipitated   Na V  channel complexes from sham and TAC mouse left ventricles using MS

Journal: The Journal of General Physiology

Article Title: Proteomic and functional mapping of cardiac Na V 1.5 channel phosphorylation sites

doi: 10.1085/jgp.202012646

Figure Lengend Snippet: Proteins identified in immunoprecipitated Na V channel complexes from sham and TAC mouse left ventricles using MS

Article Snippet: Magnetic beads were then collected and washed rapidly four times with ice-cold lysis buffer, and isolated protein complexes were eluted from the beads in 1× SDS sample buffer (Bio-Rad Laboratories) at 60°C for 10 min. 99% of the immunoprecipitated mouse left ventricular Na V channel protein complexes were analyzed by MS, and the remaining 1% were used to verify IP yields by Western blotting using a rabbit polyclonal anti-Na V 1.5 antibody (RbαNa V 1.5, 1:1,000, ASC-005; Alomone Laboratories).

Techniques: Immunoprecipitation, Sequencing

Expression of Na V 1.8 in the human atrium. Data are presented as scatter plot with mean ± SEM. P values were calculated using unpaired Student's t test. a Original Western blot for Na V 1.8 expression in atrial myocardium from patients with sinus rhythm compared to ventricular myocardium from non-failing donors (NF). b Normalized densitometry data comparing the protein expression of Na V 1.8 in human atria ( n = 6) and human ventricle ( n = 5). GAPDH was used as an internal loading control in all blots. c Normalized mRNA expression of Na V 1.8/GAPDH in human atrial myocardium ( n = 7 patients) compared to ventricular myocardium from healthy subjects ( n = 10 patients). d Original Western Blot for Na V 1.8 and Na V 1.5 protein in human atria from patients with sinus rhythm (SR) or atrial fibrillation (AF). e Normalized densitometry data from Western Blots using atrial myocardium from patients with SR or AF showing the protein expression of Na V 1.5 (SR: n = 14 patients, AF: n = 13) and ( f ) Na V 1.8 (SR: n = 14 patients, AF: n = 14). GAPDH was used as an internal loading control in all blots. g Normalized mRNA expression of Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) and Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) in human atrial myocardium from SR compared to AF

Journal: Basic Research in Cardiology

Article Title: Inhibition of Na V 1.8 prevents atrial arrhythmogenesis in human and mice

doi: 10.1007/s00395-020-0780-8

Figure Lengend Snippet: Expression of Na V 1.8 in the human atrium. Data are presented as scatter plot with mean ± SEM. P values were calculated using unpaired Student's t test. a Original Western blot for Na V 1.8 expression in atrial myocardium from patients with sinus rhythm compared to ventricular myocardium from non-failing donors (NF). b Normalized densitometry data comparing the protein expression of Na V 1.8 in human atria ( n = 6) and human ventricle ( n = 5). GAPDH was used as an internal loading control in all blots. c Normalized mRNA expression of Na V 1.8/GAPDH in human atrial myocardium ( n = 7 patients) compared to ventricular myocardium from healthy subjects ( n = 10 patients). d Original Western Blot for Na V 1.8 and Na V 1.5 protein in human atria from patients with sinus rhythm (SR) or atrial fibrillation (AF). e Normalized densitometry data from Western Blots using atrial myocardium from patients with SR or AF showing the protein expression of Na V 1.5 (SR: n = 14 patients, AF: n = 13) and ( f ) Na V 1.8 (SR: n = 14 patients, AF: n = 14). GAPDH was used as an internal loading control in all blots. g Normalized mRNA expression of Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) and Na V 1.5/GAPDH (SR: n = 8 patients, AF: n = 8) in human atrial myocardium from SR compared to AF

Article Snippet: Mouse monoclonal anti-Na V 1.8 antibodies (1:1,000, LSBio, LS-C109037), rabbit polyclonal anti-Na V 1.5 (1:2,000, Alomone labs, ASC-005), and mouse monoclonal anti-GAPDH (1:20,000, BIOTREND, BTMC-A473-9) were used.

Techniques: Expressing, Western Blot

Dose-dependent recovery of voltage-gated sodium (NaV) channel expression in dorsal root ganglia (DRG) of cilostazol-treated diabetic (DM) rats. Expressions of NaV-1.1, -1.2, -1.3, -1.6, -1.7, and -1.8 in DRG of naïve control, DM, and oral cilostazol (10, 30, and 100 mg/kg) treated DM rats were examined with (A) Western blots and (B) immunofluorescence assays. The western and immunofluorescence data revealed significant upregulation of NaV-1.1–1.7 expressions, and significant downregulation of NaV-1.8 in the DRGs of DM rats. Daily oral cilostazol treatments of 100 mg/kg, but not the lower dosages, for 6 weeks significantly reversed the DM-induced NaV dysregulation in the DRGs. Results are expressed as mean SEM for a minimum of five rats for each group. Statistical significances between the DM control and cilostazol DM treatment groups were calculated by one-way ANOVA analysis followed by the least significant difference test for multiple post hoc analyses. ** p < 0.01, * p < 0.05, *** p < 0.001.

Journal: Frontiers in Pharmacology

Article Title: Cilostazol Ameliorates Peripheral Neuropathic Pain in Streptozotocin-Induced Type I Diabetic Rats

doi: 10.3389/fphar.2021.771271

Figure Lengend Snippet: Dose-dependent recovery of voltage-gated sodium (NaV) channel expression in dorsal root ganglia (DRG) of cilostazol-treated diabetic (DM) rats. Expressions of NaV-1.1, -1.2, -1.3, -1.6, -1.7, and -1.8 in DRG of naïve control, DM, and oral cilostazol (10, 30, and 100 mg/kg) treated DM rats were examined with (A) Western blots and (B) immunofluorescence assays. The western and immunofluorescence data revealed significant upregulation of NaV-1.1–1.7 expressions, and significant downregulation of NaV-1.8 in the DRGs of DM rats. Daily oral cilostazol treatments of 100 mg/kg, but not the lower dosages, for 6 weeks significantly reversed the DM-induced NaV dysregulation in the DRGs. Results are expressed as mean SEM for a minimum of five rats for each group. Statistical significances between the DM control and cilostazol DM treatment groups were calculated by one-way ANOVA analysis followed by the least significant difference test for multiple post hoc analyses. ** p < 0.01, * p < 0.05, *** p < 0.001.

Article Snippet: The filters were blocked with 5% milk in phosphate-buffered saline (PBS) with 0.1% Tween 20 for 1 h at room temperature and incubated for 24 h at 4 C with rabbit anti-rat Navs primary antibodies (Alomone Labs, Jerusalem, Israel) included Nav-1.1 (ASC-001), Nav-1.2 (ASC-002), Nav-1.3 (ASC-004), Nav-1.6 (ASC-009), Nav-1.7 (ASC-008), Nav-1.8 (ASC-016), and mouse anti-rat ß -actin (MilliporeSigma, MAB1501).

Techniques: Expressing, Western Blot, Immunofluorescence